- 1. 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
- [selective estrogen receptor modulator; it is agonist for bone tissue and cholesterol metabolism but antagonist in mammary and uterine tissues. ( CSP )] (UMLS (NCI) C0039286) =Organic Chemical; Pharmacologic Substance ;
=amine;
Antiestrogen;
stilbene;
selective estrogen receptor modulator;
[AN500] ANTINEOPLASTIC HORMONES;
=(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine;
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate;
[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone;
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate | - 7. PBI (protein bound iodine)
- [ ] (UMLS (CSP) C0033676) =Laboratory Procedure
|
- 2. 2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine Hydrochloride
- [The hydrochloride salt form of bromodiphenhydramine, a synthetic ethanolamine with histamine H1 antagonistic and sedative properties. Bromodiphenhydramine hydrochloride blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. This drug also prevents histamine-induced pain and itching of mucous membranes. ( NCI )] (UMLS (NCI) C0304299) =Organic Chemical; Pharmacologic Substance ;
=Bromazine;
=BROMODIPHENHYDRAMINE HYDROCHLORIDE 3.75 MG;
BROMODIPHENHYDRAMINE HYDROCHLORIDE 12.5 MG/5ML;
| - 8. PBL (peripheral blood lymphocyte)
- [ ] (UMLS (CSP) C0599819) =Cell ;
|
- 3. 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate
- [The maleate salt form of brompheniramine, an alkylamine derivative and a histamine antagonist with anticholinergic and sedative properties. Brompheniramine maleate competes with histamine for the H1 receptor. This diminishes the actions of histamine on effector cells and decreases the histamine-mediated symptoms of allergic reaction such as bronchoconstriction, vasodilation, increased capillary permeability and spasmodic contractions of gastrointestinal smooth muscle. ( NCI )] (UMLS (NCI) C0546853) =Organic Chemical; Pharmacologic Substance =BROMPHENIRAMINE;
=BROMPHENIRAMINE MALEATE 4 MG/5ML;
BROMPHENIRAMINE MALEATE 10 MG/ML;
BROMPHENIRAMINE MALEATE 12 MG;
BROMPHENIRAMINE MALEATE 6 MG;
BROMPHENIRAMINE MALEATE 2 MG/5ML;
BROMPHENIRAMINE MALEATE 4 MG;
BROMPHENIRAMINE MALEATE 2 MG;
| - 9. PBMC
- [A monocyte found in the general circulation. ( NCI )] (UMLS (NCI) C1321301) Peripheral Blood Mononuclear Cell =Cell ;
|
- 4. 3-(p-(bis(2-chloroethyl)amino)phenyl)-L-Alanine, Hydrochloride
- [A bifunctional alkylating agent and phenylalanine derivative of nitrogen mustard. Melphalan hydrochloride is converted into highly reactive ethylenimmonium intermediates that induce covalent guanine N7-N7 intra- and inter-crosslinks and alkylation of adenine N3 of DNA. This agent also alkylates RNA and protein structures. As a result RNA transcription and protein synthesis are inhibited, ultimately leading to cell growth arrest and/or death. ( NCI )] (UMLS (NCI) C0771055) Melphalan Hydrochloride;
MELPHALAN HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =4-[bis(2-chloroethyl)amino]-L-phenylalanine;
=MELPHALAN HYDROCHLORIDE 50 MG;
| - 10. PBMC (peripheral blood mononuclear cell)
- [ ] (UMLS (CSP) C0599846) =Cell
|
- 5. 4-(3-(p-Butoxyphenoxy)propyl)morpholine Hydrochloride
- [The hydrochloride salt form of pramoxine, a morpholine derivative with local anesthetic property. Pramoxine hydrochloride decreases the permeability of the neuronal membrane to sodium ions by reversibly binding to and inhibiting voltage-gated sodium channels. This results in stabilization of the membrane and , thereby inhibiting the ionic fluxes required for membrane depolarization, hence resulting in the failure to initiate a propagated action potential and subsequent conduction blockade. ( NCI )] (UMLS (NCI) C0147008) =Organic Chemical; Pharmacologic Substance =pramocaine;
=PRAMOXINE HYDROCHLORIDE 1 %WW;
PRAMOXINE HYDROCHLORIDE 10 MG/GM;
PRAMOXINE HYDROCHLORIDE 0.1 %;
PRAMOXINE HYDROCHLORIDE 0.5 %;
PRAMOXINE HYDROCHLORIDE 1 % | - 11. PBPC transplantation
- [(per-IF-er-al) A method of replacing blood-forming cells destroyed by cancer treatment. Immature blood cells (stem cells) in the circulating blood that are similar to those in the bone marrow are given after treatment to help the bone marrow recover and continue producing healthy blood cells. Transplantation may be autologous (an individual's own blood cells saved earlier), allogeneic (blood cells donated by someone else), or syngeneic (blood cells donated by an identical twin). ( NCI )] (UMLS (NCI) C0242602) =Therapeutic or Preventive Procedure ;
|
- 6. PBEF
- [Pre-B-Cell Colony-Enhancing Factor, encoded by the PBEF gene, is a cytokine that acts on early B-lineage precursor cells by enhancing the effect of IL-7 and SCF on pre-B-cell colony formation. This protein is secreted and expressed in large amounts in bone marrow, liver tissue, and muscle. It is also present in heart, placenta, lung, and kidney tissues. (from LocusLink) ( NCI )] (UMLS (NCI) C0068707) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 12. PBX3
- [This gene is involved in transcriptional activation. ( NCI )] (UMLS (NCI) C1335196) PBX3 Gene;
Pre-B-Cell Leukemia Transcription Factor 3 Gene =Gene or Genome |
home
